Home > Publications database > Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential. > print |
001 | 137589 | ||
005 | 20240229105111.0 | ||
024 | 7 | _ | |a 10.1073/pnas.1720564115 |2 doi |
024 | 7 | _ | |a pmid:29895693 |2 pmid |
024 | 7 | _ | |a pmc:PMC6042091 |2 pmc |
024 | 7 | _ | |a 0027-8424 |2 ISSN |
024 | 7 | _ | |a 1091-6490 |2 ISSN |
024 | 7 | _ | |a altmetric:43641438 |2 altmetric |
037 | _ | _ | |a DKFZ-2018-01469 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 000 |
100 | 1 | _ | |a Correia, Margareta P |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential. |
260 | _ | _ | |a Washington, DC |c 2018 |b National Acad. of Sciences |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1659613705_16657 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a CD8+ T cells are considered prototypical cells of adaptive immunity. Here, we uncovered a distinct CD8+ T cell population expressing the activating natural killer (NK) receptor NKp30 in the peripheral blood of healthy individuals. We revealed that IL-15 could de novo induce NKp30 expression in a population of CD8+ T cells and drive their differentiation toward a broad innate transcriptional landscape. The adaptor FcεRIγ was concomitantly induced and was shown to be crucial to enable NKp30 cell-surface expression and function in CD8+ T cells. FcεRIγ de novo expression required promoter demethylation and was accompanied by acquisition of the signaling molecule Syk and the 'innate' transcription factor PLZF. IL-15-induced NKp30+CD8+ T cells exhibited high NK-like antitumor activity in vitro and were able to synergize with T cell receptor signaling. Importantly, this population potently controlled tumor growth in a preclinical xenograft mouse model. Our study, while blurring the borders between innate and adaptive immunity, reveals a unique NKp30+FcεRIγ+CD8+ T cell population with high antitumor therapeutic potential. |
536 | _ | _ | |a 314 - Tumor immunology (POF3-314) |0 G:(DE-HGF)POF3-314 |c POF3-314 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 7 | |a FCER1G, human |2 NLM Chemicals |
650 | _ | 7 | |a NCR3 protein, human |2 NLM Chemicals |
650 | _ | 7 | |a Natural Cytotoxicity Triggering Receptor 3 |2 NLM Chemicals |
650 | _ | 7 | |a Receptors, Fc |2 NLM Chemicals |
700 | 1 | _ | |a Stojanovic, Ana |0 P:(DE-He78)6459232320662d60ee842fd348128d87 |b 1 |u dkfz |
700 | 1 | _ | |a Bauer, Katharina |0 P:(DE-He78)5b10e57ed1df98e2fd31edbdeed985ba |b 2 |u dkfz |
700 | 1 | _ | |a Juraeva, Dilafruz |0 P:(DE-He78)5482b9f7e4c4ff6a3a4d7c860a1bce61 |b 3 |u dkfz |
700 | 1 | _ | |a Tykocinski, Lars-Oliver |b 4 |
700 | 1 | _ | |a Lorenz, Hanns-Martin |b 5 |
700 | 1 | _ | |a Brors, Benedikt |0 P:(DE-He78)fc949170377b58098e46141d95c72661 |b 6 |u dkfz |
700 | 1 | _ | |a Cerwenka, Adelheid |0 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f |b 7 |e Last author |u dkfz |
773 | _ | _ | |a 10.1073/pnas.1720564115 |g Vol. 115, no. 26, p. E5980 - E5989 |0 PERI:(DE-600)1461794-8 |n 26 |p E5980 - E5989 |t Proceedings of the National Academy of Sciences of the United States of America |v 115 |y 2018 |x 1091-6490 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:137589 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)6459232320662d60ee842fd348128d87 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)5b10e57ed1df98e2fd31edbdeed985ba |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)5482b9f7e4c4ff6a3a4d7c860a1bce61 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)fc949170377b58098e46141d95c72661 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-314 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Tumor immunology |x 0 |
914 | 1 | _ | |y 2018 |
915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b P NATL ACAD SCI USA : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b P NATL ACAD SCI USA : 2015 |
920 | 1 | _ | |0 I:(DE-He78)D080-20160331 |k D080 |l Nachwuchsgruppe Angeborene Immunität |x 0 |
920 | 1 | _ | |0 I:(DE-He78)G200-20160331 |k G200 |l Angewandte Bioinformatik |x 1 |
920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D080-20160331 |
980 | _ | _ | |a I:(DE-He78)G200-20160331 |
980 | _ | _ | |a I:(DE-He78)L101-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|